GlobeNewswire: VIVO Cannabis Inc. Contains the last 10 of 67 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T11:05:00ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/10/06/2104598/0/en/VIVO-Cannabis-Announces-Fully-Marketed-5-Million-Public-Offering.html?f=22&fvtc=4&fvtv=32352VIVO Cannabis™ Announces Fully Marketed $5 Million Public Offering2020-10-06T20:07:11Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES]]>https://www.globenewswire.com/news-release/2018/12/18/1668592/0/en/VIVO-Announces-Appointment-of-President-European-Operations.html?f=22&fvtc=4&fvtv=32352VIVO Announces Appointment of President, European Operations2018-12-18T12:00:00Z<![CDATA[NAPANEE, Ontario, Dec. 18, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce the appointment of Andreas Sander as President, European Operations, and Managing Director of ABcann Germany GmbH, VIVO’s German subsidiary. Mr. Sander will assume the position effective January 1, 2019.]]>https://www.globenewswire.com/news-release/2018/12/12/1665789/0/en/VIVO-Announces-Stock-Option-Grants.html?f=22&fvtc=4&fvtv=32352VIVO Announces Stock Option Grants2018-12-12T12:00:00Z<![CDATA[NAPANEE, Ontario, Dec. 12, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that it has granted, effective today, an aggregate of 2,790,500 stock options (each, an “Option”) to certain directors, officers, employees and consultants of the Company in accordance with the Company’s stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a “Share”) at a price of $0.89 per Share, being the closing price of the Shares on the TSX Venture Exchange on December 11, 2018, for a period of five years from the date of grant. The Options will vest in equal quarterly instalments over 36 months. Including this grant of Options, the Company has granted less than 50% of the Options available for grant under its stock option plan.]]>https://www.globenewswire.com/news-release/2018/12/04/1661527/0/en/Canna-Farms-Wins-Top-Reviewed-Licensed-Producer-of-the-Year-Award.html?f=22&fvtc=4&fvtv=32352Canna Farms Wins Top Reviewed Licensed Producer of the Year Award2018-12-04T12:00:00Z<![CDATA[NAPANEE, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), was recognized as the Top Reviewed Licensed Producer of the Year at the recent Canadian Cannabis Awards. The award, announced on November 29, 2018 and chosen by Lift & Co., was based on the overall volume and quality of reviews of Licensed Producers on the Lift.co website.]]>https://www.globenewswire.com/news-release/2018/11/30/1659933/0/en/VIVO-Cannabis-Reports-Record-Revenue-for-Q3-2018.html?f=22&fvtc=4&fvtv=32352VIVO Cannabis™ Reports Record Revenue for Q3 20182018-11-30T12:00:00Z<![CDATA[NAPANEE, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, ABcann Medicinals Inc. (“ABcann”) and Canna Farms Limited (“Canna Farms”), is pleased to announce the release of its financial results for the three and nine months ended September 30, 2018. The results represent the Company’s strongest financial performance to date.]]>https://www.globenewswire.com/news-release/2018/10/30/1638964/0/en/Harvest-Medicine-Launches-Free-Medical-Cannabis-Telemedicine-Platform.html?f=22&fvtc=4&fvtv=32352Harvest Medicine Launches Free Medical Cannabis Telemedicine Platform2018-10-30T11:00:00Z<![CDATA[NAPANEE, Ontario, Oct. 30, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), one of Canada’s fastest growing specialty medical cannabis clinic networks, is launching a free telemedicine service for medical cannabis care and education via an app.]]>https://www.globenewswire.com/news-release/2018/10/23/1625638/0/en/VIVO-Announces-Initial-5-Million-Strategic-Investment-in-National-Access-Cannabis.html?f=22&fvtc=4&fvtv=32352VIVO Announces Initial $5 Million Strategic Investment in National Access Cannabis2018-10-23T14:44:31Z<![CDATA[NAPANEE, Ontario, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has agreed to make a $5 million strategic investment in National Access Cannabis Corp. (TSXV: META) (“NAC”), and commited to invest an additional $5 million contingent on attainment of a growth-related milestone and the satisfaction of certain other conditions precedent. NAC intends to use the proceeds of the investment, and additional recent and proposed financings, to advance the roll out of its retail cannabis operations across Canada. NAC’s vision is to be one of the largest adult-use retailers in Canada, with over 200 locations providing safe and responsible access to legal cannabis in Canadian private retail markets, subject to licensing and regulatory approvals.]]>https://www.globenewswire.com/news-release/2018/10/23/1625274/0/en/Harvest-Medicine-Signs-Agreement-with-Think-Research-to-Improve-Coordination-of-Medical-Cannabis-Care.html?f=22&fvtc=4&fvtv=32352Harvest Medicine Signs Agreement with Think Research to Improve Coordination of Medical Cannabis Care2018-10-23T11:00:00Z<![CDATA[NAPANEE, Ontario, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has signed an agreement with Think Research, a leading digital healthcare platform provider, to bring innovative digital healthcare solutions to its national medical cannabis care and education platform. Harvest Medicine is the first medical cannabis care network to leverage this innovative technology.]]>https://www.globenewswire.com/news-release/2018/10/17/1622512/0/en/Harvest-Medicine-Continues-National-Expansion-with-Acquisition-of-Trauma-Healing-Centres.html?f=22&fvtc=4&fvtv=32352Harvest Medicine Continues National Expansion with Acquisition of Trauma Healing Centres2018-10-17T11:00:00Z<![CDATA[NAPANEE, Ontario, Oct. 17, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has completed the acquisition of Trauma Healing Centres (“THC”) from Organigram Holdings Inc..]]>https://www.globenewswire.com/news-release/2018/10/05/1617340/0/en/VIVO-and-Loyalist-College-Collaborate-on-Cannabis-Applied-Research-Project.html?f=22&fvtc=4&fvtv=32352VIVO and Loyalist College Collaborate on Cannabis Applied Research Project2018-10-05T11:00:00Z<![CDATA[NAPANEE, Ontario, Oct. 05, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSXV:VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), through its wholly owned subsidiary ABcann Medicinals Inc., and Loyalist College’s Applied Research Centre for Natural Products and Medical Cannabis (ARC) have entered into an applied research agreement to investigate and develop innovative processes for the extraction and formulation of cannabis oil for commercialization.]]>